ESGCT 30th ANNUAL CONGRESS BRUSSELS
Date: Oct 24, 2023
Join us at Booth #107 during the 30th annual European Society of Cell and Gene Therapy meeting in the vibrant city of Brussels from October 24-27, 2023.
The congress is a prominent gathering in the field of gene therapy, cell therapy, and genetic vaccines. It fosters both basic and clinical research by promoting education, facilitating information exchange, and advancing technology. The congress will feature a range of activities such as keynote lectures, plenary sessions, poster presentations, and more.
Gene Therapy Research Solutions:
- Full-Service Gene Therapy CRO Platform
-
Advanced Bioinformatics Platform
- Leading AI technology used to optimize AAV design
- Risk prediction of pathogenic mutation site
- In vivo and in vitro models: one-stop service
Cell Therapy Research Solutions:
- We provide one-stop in vitro and in vivo research services
- Mature lentivirus packaging and CAR-T/NK cell generation platform
- Extensive catalog of tumor cell and mouse models
- Standardized and personalized drug efficacy evaluation services
Have questions for our specialists or want more information?
Request a meeting in-person at ESGCT to discuss your project.
Click here to book the in-person meeting!
Our booth will feature exciting new developments in the field of gene therapy, and our team will be on hand to answer any questions and share insights. We look forward to seeing you there!
Contact us for a free consultation on your CAM/CGT projects.
Founded in 2006, Cyagen is a global provider of genetically modified rodent models and innovative cell and gene therapy (CGT) solutions for research and development (R&D), including: disease model development, AAV discovery, drug efficacy studies, and more. The company has established extensive cooperations with scientists and institutions in more than 100 countries, leading to the publication of over 6,300 academic articles, many of which were in the three major journals of CNS (Cell, Nature, Science). From its robust foundation in animal model development, to implementation of artificial intelligence (AI)-powered tools for data analysis and therapeutic discoveries, Cyagen provides one-stop solutions for accelerating basic research and new drug R&D with our unique offering of models, data, algorithms, and services.
